JAKARTA: Pharmaceutical-related company PT Indofarma Tbk is projected to conduct selection over underwriter this month following its bonds issuance plan.
The company recently completed rating process from PT Pemeringkat Efek Indonesia, said Corporate Secretary Ahdia Amini. The result will be published next week.
After getting the ratings for the bonds, he said, the company still have to ask Ministry of State-Owned Enterprises (SOE) approval as the majority shareholder. After that, the selection of underwriters will be implemented.
“We are planning to issue bonds worth approximately IDR500 billion-IDR600 billion,” he said on Wednesday, (7/4/2012).
The state-controlled company will select both national and private securities to manage the corporate action.
The company will issue the bonds in stages. As for the first stage, Indofarma might issue bonds worth IDR300 billion.
The potential proceeds will be used to add capital expenditure, expansion and refinancing. (T05)
The potential proceeds will be used to add capital expenditure, expansion and refinancing. (T05)
Showing 0 - 0 of 0 comments